Eli Lilly Recalls ERBITUX Vials Due to Missing Primary Container Labels
Eli Lilly is recalling 9,380 vials of ERBITUX (cetuximab) because some may be missing primary container labels. The recall covers specific states and Puerto Rico.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which indicates a low risk of adverse health consequences. The hazard is a packaging/labeling defect (missing label) rather than a contamination or functional defect.
Plain-English summary
Eli Lilly & Co is recalling 9,380 vials of ERBITUX (cetuximab) Injection, 200 mg/100 mL (2 mg/mL). The recall is due to a labeling issue where the primary container label on the vial may be missing.
The affected product is Lot number C1700167, with an expiration date of 9/2020. The product was distributed to Alabama, Arizona, California, Kansas, Louisiana, Mississippi, Ohio, Oregon, Tennessee, Texas, and Puerto Rico.
Consumers and healthcare providers should check their inventory for this specific lot number and expiration date. If the primary container label is missing, the product should not be used. Contact Eli Lilly & Co for further instructions or to arrange for the return of the affected product.
The recalled product
- Product
- ERBITUX (CETUXIMAB)
- Brand
- ERBITUX
- Manufacturer
- Eli Lilly & Co
- Category
- Drug — Prescription Injection
- Hazard
- Affected units
- 9,380
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot number: C1700167
- exp 9/2020
Distribution
Related recalls
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02